Cost-Utility Analysis of Delayed-Release Dimethyl Fumerate For The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal
Abstract
Authors
L Silva Miguel J de Sá B Pinheiro C Acosta
L Silva Miguel J de Sá B Pinheiro C Acosta
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now